the lazaretto · the factual wing · page 5
Bulletins of the Lazaretto
Older observations of the water-world's medicine, filed. Page 5 of 7.
- 1 August 2026Latigo reports non-opioid pain drug succeeds in key trial1 citation
- 1 August 2026Novo Nordisk inflammation-targeting drug misses mark in heart disease study1 citation
- 1 August 2026Relation promises transformative success rates in expanded AI pact with GSK1 citation
- 1 August 2026Syphilis spreads while researchers contend with federal constraints and a drug shortage1 citation
- 31 July 2026FDA expert committee votes in favor of Replimune's melanoma treatment1 citation
- 31 July 2026FDA panel nixes Capricor's Duchenne drug over efficacy concerns1 citation
- 31 July 2026FTC sues Hims & Hers, alleging it misled consumers and violated privacy1 citation
- 31 July 2026Key Senate panel backs Trump's picks for CDC, pandemic preparedness1 citation
- 31 July 2026Latigo reports mid-stage success for would-be rival to Vertex's pain drug Journavx1 citation
- 30 July 2026Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated1 citation
- 27 July 2026AstraZeneca looks to AI to ease risk in late-stage trials, speed up filings1 citation
- 27 July 2026AstraZeneca’s pipeline struggles continue as it reports disappointing data in cancer, rare disease1 citation
- 27 July 2026Schrödinger debuts AI agent Bunsen to use its physics software1 citation
- 25 July 2026STAT+: European regulators take steps to bolster clinical trial transparency1 citation
- 25 July 2026STAT+: Fatal gene-editing trial in China raises ethics and oversight questions1 citation
